Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudotumor Cerebri | 3 | 2013 | 3 | 0.900 |
Why?
|
| Obesity | 2 | 2013 | 309 | 0.650 |
Why?
|
| Enophthalmos | 1 | 2016 | 1 | 0.530 |
Why?
|
| Scleroderma, Localized | 1 | 2016 | 5 | 0.530 |
Why?
|
| Diplopia | 1 | 2016 | 3 | 0.530 |
Why?
|
| Visual Fields | 1 | 2014 | 3 | 0.450 |
Why?
|
| Perceptual Disorders | 1 | 2014 | 4 | 0.450 |
Why?
|
| Automobile Driving | 1 | 2014 | 21 | 0.440 |
Why?
|
| Papilledema | 1 | 2013 | 1 | 0.410 |
Why?
|
| Vision Disorders | 1 | 2013 | 20 | 0.410 |
Why?
|
| Chin | 1 | 2011 | 2 | 0.370 |
Why?
|
| Mouth, Edentulous | 1 | 2011 | 3 | 0.370 |
Why?
|
| Hypesthesia | 1 | 2011 | 6 | 0.370 |
Why?
|
| Ophthalmology | 1 | 2011 | 4 | 0.350 |
Why?
|
| Body Mass Index | 1 | 2013 | 462 | 0.340 |
Why?
|
| Neurology | 1 | 2011 | 38 | 0.340 |
Why?
|
| Clinical Protocols | 1 | 2009 | 58 | 0.300 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 8 | 0.260 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2006 | 5 | 0.260 |
Why?
|
| Diseases in Twins | 1 | 2006 | 9 | 0.260 |
Why?
|
| Stroke | 1 | 2009 | 269 | 0.240 |
Why?
|
| Intracranial Hypertension | 1 | 2023 | 14 | 0.210 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2023 | 15 | 0.210 |
Why?
|
| Humans | 10 | 2023 | 27263 | 0.190 |
Why?
|
| Hypoxia | 1 | 2020 | 32 | 0.170 |
Why?
|
| Neurologic Examination | 2 | 2011 | 101 | 0.160 |
Why?
|
| Female | 6 | 2020 | 15332 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2011 | 43 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 121 | 0.150 |
Why?
|
| Adult | 4 | 2020 | 7944 | 0.140 |
Why?
|
| Male | 5 | 2020 | 14878 | 0.130 |
Why?
|
| Middle Aged | 3 | 2014 | 9068 | 0.120 |
Why?
|
| Visual Field Tests | 1 | 2014 | 2 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2014 | 62 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3550 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2013 | 42 | 0.100 |
Why?
|
| Incidence | 1 | 2014 | 763 | 0.090 |
Why?
|
| Mandible | 1 | 2011 | 12 | 0.090 |
Why?
|
| Ubiquinone | 1 | 2011 | 1 | 0.090 |
Why?
|
| Burkholderia | 1 | 2011 | 1 | 0.090 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2011 | 2 | 0.090 |
Why?
|
| Retinal Artery Occlusion | 1 | 2011 | 3 | 0.090 |
Why?
|
| Giant Cell Arteritis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 15 | 0.090 |
Why?
|
| Canada | 1 | 2011 | 46 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 164 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2011 | 123 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2023 | 3540 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2011 | 95 | 0.080 |
Why?
|
| Emergencies | 1 | 2009 | 32 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2009 | 49 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 667 | 0.070 |
Why?
|
| Adolescent | 1 | 2013 | 2185 | 0.070 |
Why?
|
| Risk Factors | 1 | 2013 | 2335 | 0.070 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pedigree | 1 | 2006 | 55 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 9120 | 0.060 |
Why?
|
| Infant | 1 | 2006 | 517 | 0.060 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2023 | 24 | 0.050 |
Why?
|
| Encephalocele | 1 | 2023 | 26 | 0.050 |
Why?
|
| Skull Base | 1 | 2023 | 35 | 0.050 |
Why?
|
| Child | 1 | 2006 | 1268 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 217 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2023 | 589 | 0.050 |
Why?
|
| Illinois | 1 | 2020 | 250 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 488 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 243 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 1108 | 0.030 |
Why?
|